`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`———————
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`———————
`
`
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner,
`
`v.
`
`NOVARTIS PHARMA AG,
`NOVARTIS TECHNOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owner
`
`———————
`
`Case No. Unassigned
`U.S. Patent No. 9,220,631
`———————
`POWER OF ATTORNEY FOR PETITIONER
`REGENERON PHARMACEUTICALS, INC.
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.l0(b), Petitioner Regeneron Pharmaceuticals,
`
`Inc., hereby appoints the following practitioners as their attorneys to transact all
`
`business in the United States Patent & Trademark Office connected to the above
`
`captioned Inter Partes Review of U.S. Patent No. 9,220,631:
`
`LEAD COUNSEL
`Elizabeth Stotland Weiswasser
`Reg. No. 55,721
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`elizabeth.weiswasser@weil.com
`Phone: 212-310-8022
`Fax: 212-310-8007
`
`
`
`Service E-mail:
`Regeneron.IPR.Service@weil.com
`
`BACK-UP COUNSEL
`Anish R. Desai
`Reg. No. 73,760
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`anish.desai@weil.com
`Phone: 212-310-8730
`Fax: 212-310-8007
`Brian E. Ferguson
`Reg. No. 36,801
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`brian.ferguson@weil.com
`Phone: 202-682-7516
`Fax: 202-857-0940
`Christopher M. Pepe
`Reg. No. 73,851
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`christopher.pepe@weil.com
`Phone: 202-682-7018
`Fax: 202-857-0940
`
`
`
`1
`
`
`
`Natalie C. Kennedy
`Reg. No. 68,511
`Weil, Gotshal & Manges LLP
`767 F ifih Avenue
`
`New York, NY 10153
`natalie.kennedy@weil.com
`Phone: 212-3 10-8227
`
`Fax: 212-310-8007
`
`Andrew P. Gesior
`
`
`
`Reg. No. 76,588
`Weil, GOtshal & Manges LLP
`767 Fifih Avenue
`
`New York, NY 10153
`andrew.gesior@weil.com
`Phone: 212-3 10-8244
`
`Fax: 212-310-8007
`
`Priyata Y. Patel
`Reg. No. 76,861
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, DC. 20036
`priyata.patel@weil.com
`Phone: 202-682-7041
`
`Fax: 202-857-0940
`
`The undersigned has the authority to execute this document on behalf of
`
`Petitioner Regeneron Pharmaceuticals, Inc.
`
`Dated: April 14, 2021
`
`/
`Larry oury
`Vice President,
`
`/
`
`Associate General Counsel
`
`Regeneron Pharmaceuticals, Inc.
`
`